A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT05185622 · COMPLETED
Trial details
- NCT number
- NCT05185622
- Sponsor
- Santhera Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-21
- Primary completion
- 2024-07-16
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.